Evidence map›Paper›PMID 41038829›Full record

ArticleNature communications2025

The assembly of a hybrid type IV secretion system by a Crohn's disease-associated Escherichia coli strain.

Jonas Wong, Ahmad Refaat, Pablo Villacampa-Teixeira, Jonasz B Patkowski, Natalie Lapa, Julian Ortiz, Kasia Dzierlega, Blake Roberts, Stephanie Tollenaar, Matthew Croxen and 6 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Jonas WongDepartment of Medical Microbiology & Immunology, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Canada.ORCID http://orcid.org/0009-0006-5611-1748
Ahmad RefaatDepartment of Medical Microbiology & Immunology, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Canada.ORCID http://orcid.org/0009-0003-4188-7197
Pablo Villacampa-TeixeiraCentre for Bacterial Resistance Biology, Imperial College London, London, UK.ORCID http://orcid.org/0009-0002-3201-3394
Jonasz B PatkowskiCentre for Bacterial Resistance Biology, Imperial College London, London, UK.ORCID http://orcid.org/0000-0001-7301-1569
Natalie LapaDepartment of Medical Microbiology & Immunology, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Canada.
Julian OrtizDepartment of Medical Microbiology & Immunology, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Canada.
Kasia DzierlegaDepartment of Medical Microbiology & Immunology, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Canada.
Blake RobertsDepartment of Medical Microbiology & Immunology, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Canada.
Stephanie TollenaarDepartment of Agricultural, Food & Nutritional Science, Faculty of Agricultural, Life & Environmental Sciences, University of Alberta, Edmonton, Canada.ORCID http://orcid.org/0000-0002-3520-6987
Matthew CroxenLi Ka Shing Institute of Virology, Edmonton, Canada.
Aducio ThiesenDepartment of Laboratory Medicine and Pathology, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Canada.
Dina KaoDivision of Gastroenterology, Department of Medicine, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Canada.ORCID http://orcid.org/0000-0002-6096-0586
Ben WillingDepartment of Agricultural, Food & Nutritional Science, Faculty of Agricultural, Life & Environmental Sciences, University of Alberta, Edmonton, Canada.ORCID http://orcid.org/0000-0003-4285-4728
Xavier Clemente-CasaresDepartment of Medical Microbiology & Immunology, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Canada.ORCID http://orcid.org/0000-0002-8627-4971
Tiago R D CostaCentre for Bacterial Resistance Biology, Imperial College London, London, UK. t.costa@imperial.ac.uk.ORCID http://orcid.org/0000-0003-2716-9669
Wael ElhenawyDepartment of Medical Microbiology & Immunology, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Canada. elhenawy@ualberta.ca.ORCID http://orcid.org/0000-0002-4599-8500

Funding

Canada Research Chairs (Chaires de recherche du Canada) CRC-00249Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) RES0069043Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (Conseil de Recherches en Sciences Naturelles et en Génie du Canada) DGECR-2023-00140
6 · The paper itself

Abstract

Type IV secretion systems (T4SSs) are central to bacterial pathogenesis. Traditionally known for facilitating DNA transfer via conjugation, T4SSs also mediate biofilm formation. These biofilms are critical for the fitness of adherent-invasive Escherichia coli (AIEC), which are commonly isolated from Crohn's disease patients and are known for propelling gut inflammation. Many AIEC strains carry F-like plasmids encoding the IncF subgroup of T4SSs. Unlike minimized systems with 12 core components, the IncF family is an expanded T4SS with additional genes that enhance conjugation. Here, we show that a biofilm-forming AIEC strain harbors an unusual IncF plasmid that lacks two conserved components essential for T4SS functionality. This strain forms a natural hybrid T4SS where the missing components are supplied by a co-residing chromosomal T4SS on an integrative and conjugative element (ICE). Biochemical assays reveal that this hybrid T4SS drives pilin polymerization and biofilm formation on epithelial cells. Furthermore, we show that a bacterial subpopulation expresses the IncF and ICE-encoded genes in response to host cells, leading to the assembly of biofilms and enhanced fitness in the gut. These findings uncover crosstalk between two evolutionary distant mobile genetic elements to form a hybrid T4SS that mediates biofilm biogenesis by a Crohn's disease-associated pathogen.

Indexed as

Crohn DiseaseEscherichia coliEscherichia coli InfectionsType IV Secretion SystemsBiofilmsConjugation, GeneticEpithelial CellsEscherichia coli ProteinsHumansPlasmidsEscherichia coli ProteinsType IV Secretion Systems

Identifiers

PMID41038829
PMCPMC12491478

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.